{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:13:33Z","timestamp":1771877613328,"version":"3.50.1"},"reference-count":64,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2024.14354","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T11:37:15Z","timestamp":1711107435000},"source":"Crossref","is-referenced-by-count":1,"title":["Simultaneous blastic plasmacytoid dendritic cell neoplasm and myelofibrosis: A case report"],"prefix":"10.3892","volume":"27","author":[{"given":"Fuyi","family":"Luo","sequence":"first","affiliation":[{"name":"Graduate School, Hebei North University, Zhangjiakou, Hebei 075000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hebei Province Hospital of Chinese Medicine, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hebei General Hospital, Shijiazhuang, Hebei 050000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"key20240412091949_b1-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.leukres.2018.08.014","article-title":"Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm","volume":"73","author":"Guru Murthy","year":"2018","journal-title":"Leuk Res"},{"key":"key20240412091949_b2-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3324\/haematol.2012.072645","article-title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: An Italian multicenter study","volume":"98","author":"Pagano","year":"2013","journal-title":"Haematologica"},{"key":"key20240412091949_b3-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"515","DOI":"10.6004\/jnccn.2023.7026","article-title":"Blastic plasmacytoid dendritic cell neoplasm","volume":"21","author":"Jain","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"key20240412091949_b4-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1182\/bloodadvances.2019000647","article-title":"How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?","volume":"3","author":"Garnache-Ottou","year":"2019","journal-title":"Blood Adv"},{"key":"key20240412091949_b5-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"key20240412091949_b6-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol"},{"key":"key20240412091949_b7-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.2022017865","article-title":"North American blastic plasmacytoid dendritic cell neoplasm consortium: Position on standards of care and areas of need","volume":"141","author":"Pemmaraju","year":"2023","journal-title":"Blood"},{"key":"key20240412091949_b8-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1182\/bloodadvances.2020001875","article-title":"Survival outcomes in blastic plasmacytoid dendritic cell neoplasm by first-line treatment and stem cell transplant","volume":"4","author":"Yun","year":"2020","journal-title":"Blood Adv"},{"key":"key20240412091949_b9-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1182\/blood.2019001144","article-title":"Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark","volume":"134","author":"Taylor","year":"2019","journal-title":"Blood"},{"key":"key20240412091949_b10-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1178147","DOI":"10.3389\/fonc.2023.1178147","article-title":"Primary blastic plasmacytoid dendritic cell neoplasm: A US population-based study","volume":"13","author":"Huang","year":"2023","journal-title":"Front Oncol"},{"key":"key20240412091949_b11-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"7007","DOI":"10.1182\/bloodadvances.2023011308","article-title":"Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: A CIBMTR analysis","volume":"7","author":"Murthy","year":"2023","journal-title":"Blood Adv"},{"key":"key20240412091949_b12-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 Update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"key20240412091949_b13-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ajh.23690","article-title":"How common are myeloproliferative neoplasms? A systematic review and meta-analysis","volume":"89","author":"Titmarsh","year":"2014","journal-title":"Am J Hematol"},{"key":"key20240412091949_b14-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1182\/blood-2008-07-170449","article-title":"New prognostic scoring system for primary myelofibrosis based on a study of the international working group for myelofibrosis research and treatment","volume":"113","author":"Cervantes","year":"2009","journal-title":"Blood"},{"key":"key20240412091949_b15-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/bjh.19164","article-title":"The management of myelofibrosis: A British society for haematology guideline","volume":"204","author":"McLornan","year":"2024","journal-title":"Br J Haematol"},{"key":"key20240412091949_b16-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12885-022-10495-6","article-title":"Trends in overall mortality among US veterans with primary myelofibrosis","volume":"23","author":"Tashi","year":"2023","journal-title":"BMC Cancer"},{"key":"key20240412091949_b17-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000101708","article-title":"Myelofibrosis-what's in a name? Consensus on definition and EUMNET grading","volume":"74","author":"Thiele","year":"2007","journal-title":"Pathobiology"},{"key":"key20240412091949_b18-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.2147\/CMAR.S258875","article-title":"Patients of myelodysplastic syndrome with mild\/moderate myelofibrosis and a monosomal karyotype are independently associated with an adverse prognosis: Long-term follow-up data","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag Res"},{"key":"key20240412091949_b19-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1172\/JCI19540","article-title":"TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia","volume":"113","author":"Shehata","year":"2004","journal-title":"J Clin Invest"},{"key":"key20240412091949_b20-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1066896920938130","article-title":"E-cadherin expression in blastic plasmacytoid dendritic cell neoplasms: An unrecognized finding and potential diagnostic pitfall","volume":"29","author":"Shenjere","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"key20240412091949_b21-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"key20240412091949_b22-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"Fastp: An ultra-fast all-in-one fastq preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"key20240412091949_b23-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative genomics viewer (IGV): High-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsd\u00f3ttir","year":"2013","journal-title":"Brief Bioinform"},{"key":"key20240412091949_b24-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: Genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput Biol"},{"key":"key20240412091949_b25-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-1-4939-8666-8_7","article-title":"Split-read indel and structural variant calling using pindel","volume":"1833","author":"Ye","year":"2018","journal-title":"Methods Mol Biol"},{"key":"key20240412091949_b26-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jmoldx.2021.07.012","article-title":"Accurate detection and quantification of FLT3 internal tandem duplications in clinical hybrid capture next-generation sequencing data","volume":"23","author":"Tung","year":"2021","journal-title":"J Mol Diagn"},{"key":"key20240412091949_b27-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ajh.2830470406","article-title":"High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma","volume":"47","author":"Adachi","year":"1994","journal-title":"Am J Hematol"},{"key":"key20240412091949_b28-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: Clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20240412091949_b29-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"key20240412091949_b30-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.2147\/OTT.S313428","article-title":"Simultaneous follicular lymphoma and myelofibrosis: Report of a case with review of the literature","volume":"14","author":"Kong","year":"2021","journal-title":"Onco Targets Ther"},{"key":"key20240412091949_b31-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/ejh.14064","article-title":"An overlooked mimic? Autoimmune myelofibrosis-A scoping review of the literature","volume":"111","author":"Amel Riazat-Kesh","year":"2023","journal-title":"Eur J Haematol"},{"key":"key20240412091949_b32-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41408-019-0262-0","article-title":"Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)","volume":"9","author":"Beird","year":"2019","journal-title":"Blood Cancer J"},{"key":"key20240412091949_b33-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00277-011-1342-9","article-title":"Follicular lymphoma with prominent fibrosis complicated by peripheral eosinophilia","volume":"91","author":"Tabata","year":"2012","journal-title":"Ann Hematol"},{"key":"key20240412091949_b34-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1182\/asheducation-2018.1.118","article-title":"Managing myelofibrosis (MF) that \u2018blasts\u2019 through: Advancements in the treatment of relapsed\/refractory and blast-phase MF","volume":"2018","author":"Scherber","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"key20240412091949_b35-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/10428190400029809","article-title":"Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-beta1","volume":"46","author":"Okabe","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"key20240412091949_b36-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1159\/000504129","article-title":"Splenic marginal zone lymphoma with prominent myelofibrosis mimicking triple-negative primary myelofibrosis","volume":"12","author":"Tsutsui","year":"2019","journal-title":"Case Rep Oncol"},{"key":"key20240412091949_b37-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00277-003-0806-y","article-title":"Splenic marginal zone lymphoma presenting as myelofibrosis associated with bone marrow involvement of lymphoma cells which secrete a large amount of TGF-beta","volume":"83","author":"Matsunaga","year":"2004","journal-title":"Ann Hematol"},{"key":"key20240412091949_b38-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/cas.12484","article-title":"TET2 as an epigenetic master regulator for normal and malignant hematopoiesis","volume":"105","author":"Nakajima","year":"2014","journal-title":"Cancer Sci"},{"key":"key20240412091949_b39-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1182\/blood-2009-03-210039","article-title":"Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies","volume":"114","author":"Abdel-Wahab","year":"2009","journal-title":"Blood"},{"key":"key20240412091949_b40-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1056\/NEJMoa0810069","article-title":"Mutation in Tet2 in myeloid cancers","volume":"360","author":"Delhommeau","year":"2009","journal-title":"N Eng J Med"},{"key":"key20240412091949_b41-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","article-title":"Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms","volume":"129","author":"Vainchenker","year":"2017","journal-title":"Blood"},{"key":"key20240412091949_b42-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.stemcr.2020.02.011","article-title":"Divergent effects of Dnmt3a and Tet2 mutations on hematopoietic progenitor cell fitness","volume":"14","author":"Ostrander","year":"2020","journal-title":"Stem Cell Reports"},{"key":"key20240412091949_b43-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrc2175","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20240412091949_b44-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.3390\/ijms24044079","article-title":"Dis3: The enigmatic gene in multiple myeloma","volume":"24","author":"Ohguchi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"key20240412091949_b45-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.7150\/ijbs.23802","article-title":"Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-\u03baB pathway","volume":"15","author":"Chen","year":"2019","journal-title":"Int J Biol Sci"},{"key":"key20240412091949_b46-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1182\/blood-2012-11-469619","article-title":"BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders","volume":"122","author":"Damm","year":"2013","journal-title":"Blood"},{"key":"key20240412091949_b47-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1182\/blood.2021010958","article-title":"BCOR gene alterations in hematologic diseases","volume":"138","author":"Sportoletti","year":"2021","journal-title":"Blood"},{"key":"key20240412091949_b48-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/jclinpath-2019-206132","article-title":"Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome","volume":"73","author":"Badaat","year":"2020","journal-title":"J Clin Pathol"},{"key":"key20240412091949_b49-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1182\/blood-2010-05-286757","article-title":"Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease","volume":"117","author":"Elling","year":"2011","journal-title":"Blood"},{"key":"key20240412091949_b50-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/bjh.18008","article-title":"Novel PDGFRA mutation in blastic plasmacytoid dendritic cell neoplasm; possible therapeutic implications","volume":"197","author":"Abdulbaki","year":"2022","journal-title":"Br J Haematol"},{"key":"key20240412091949_b51-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: An update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"key20240412091949_b52-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1084\/jem.20160283","article-title":"Role of neoplastic monocyte-derived fibrocytes in primary myelofibrosis","volume":"213","author":"Verstovsek","year":"2016","journal-title":"J Exp Med"},{"key":"key20240412091949_b53-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/cells10051034","article-title":"Next generation therapeutics for the treatment of myelofibrosis","volume":"10","author":"Tremblay","year":"2021","journal-title":"Cells"},{"key":"key20240412091949_b54-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1056\/NEJMoa2118024","article-title":"Trial of anti-BDCA2 antibody litifilimab for cutaneous lupus erythematosus","volume":"387","author":"Werth","year":"2022","journal-title":"N Engl J Med"},{"key":"key20240412091949_b55-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ccell.2016.10.002","article-title":"A druggable TCF4- and BRD4-dependent transcriptional network sustains malignancy in blastic plasmacytoid dendritic cell neoplasm","volume":"30","author":"Ceribelli","year":"2016","journal-title":"Cancer Cell"},{"key":"key20240412091949_b56-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1158\/2159-8290.CD-16-0999","article-title":"Blastic Plasmacytoid dendritic cell neoplasm is dependent on BCL2 and sensitive to venetoclax","volume":"7","author":"Montero","year":"2017","journal-title":"Cancer Discov"},{"key":"key20240412091949_b57-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3324\/haematol.2018.202093","article-title":"Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target","volume":"104","author":"Sapienza","year":"2019","journal-title":"Haematologica"},{"key":"key20240412091949_b58-ol-27-5-14354","first-page":"e33109","article-title":"Venetoclax and Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm refractory to conventional therapy","volume":"14","author":"Azad","year":"2022","journal-title":"Cureus"},{"key":"key20240412091949_b59-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/1078155220951850","article-title":"Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review","volume":"27","author":"Samhouri","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"key20240412091949_b60-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1172\/JCI128571","article-title":"DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance","volume":"129","author":"Togami","year":"2019","journal-title":"J Clin Invest"},{"key":"key20240412091949_b61-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41573-020-0089-1","article-title":"RAS-targeted therapies: Is the undruggable drugged?","volume":"19","author":"Moore","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"key20240412091949_b62-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1517\/14740338.2016.1146675","article-title":"Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma","volume":"15","author":"Lyman","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"key20240412091949_b63-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.6004\/jnccn.2015.0014","article-title":"Management of chemotherapy-induced neutropenia: Measuring quality, cost, and value","volume":"13","author":"Dinan","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"key20240412091949_b64-ol-27-5-14354","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1007\/s12325-020-01419-6","article-title":"Patient burden and real-world management of chemotherapy-induced myelosuppression: Results from an online survey of patients with solid tumors","volume":"37","author":"Epstein","year":"2020","journal-title":"Adv Ther"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T06:19:57Z","timestamp":1712902797000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2024.14354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":64,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,22]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2024.14354","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"article-number":"220"}}